While anti-K39 antibodies serve as the primary targets for serological diagnosis of visceral leishmaniasis, their involvement in the immunopathological aspects of this disease, such as hypergammaglobulinemia, still needs to be explored. This evidence concerns the gene KRT39 and visceral leishmaniasis.